Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PDNO infusion for efficacy, safety, and tolerability in pulmonary hypertension following cardiopulmonary bypass surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• PDNO infusion (PDNO)

Snippet

Sponsor: Attgeno AB | Conditions: Pulmonary Hypertension | Phase 2 | Status: UNKNOWN